149 related articles for article (PubMed ID: 14580658)
1. Topiramate concentration in saliva: an alternative to serum monitoring.
Miles MV; Tang PH; Glauser TA; Ryan MA; Grim SA; Strawsburg RH; deGrauw TJ; Baumann RJ
Pediatr Neurol; 2003 Aug; 29(2):143-7. PubMed ID: 14580658
[TBL] [Abstract][Full Text] [Related]
2. Topiramate pharmacokinetics in children and adults with epilepsy: a case-matched comparison based on therapeutic drug monitoring data.
Battino D; Croci D; Rossini A; Messina S; Mamoli D; Perucca E
Clin Pharmacokinet; 2005; 44(4):407-16. PubMed ID: 15828853
[TBL] [Abstract][Full Text] [Related]
3. Plasma concentration of topiramate correlates with cerebrospinal fluid concentration.
Christensen J; Højskov CS; Dam M; Poulsen JH
Ther Drug Monit; 2001 Oct; 23(5):529-35. PubMed ID: 11591899
[TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of topiramate in patients with epilepsy: influence of dose, age, and comedication.
May TW; Rambeck B; Jürgens U
Ther Drug Monit; 2002 Jun; 24(3):366-74. PubMed ID: 12021627
[TBL] [Abstract][Full Text] [Related]
5. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
Otoul C; De Smedt H; Stockis A
Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
[TBL] [Abstract][Full Text] [Related]
6. Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
Contin M; Riva R; Albani F; Avoni P; Baruzzi A
Ther Drug Monit; 2002 Jun; 24(3):332-7. PubMed ID: 12021622
[TBL] [Abstract][Full Text] [Related]
7. Influence of dosage, age, and co-medication on plasma topiramate concentrations in children and adults with severe epilepsy and preliminary observations on correlations with clinical response.
Ferrari AR; Guerrini R; Gatti G; Alessandrì MG; Bonanni P; Perucca E
Ther Drug Monit; 2003 Dec; 25(6):700-8. PubMed ID: 14639056
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI
Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
[TBL] [Abstract][Full Text] [Related]
9. Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations.
Ohman I; Vitols S; Luef G; Söderfeldt B; Tomson T
Epilepsia; 2002 Oct; 43(10):1157-60. PubMed ID: 12366729
[TBL] [Abstract][Full Text] [Related]
10. Saliva and serum concentration of lamotrigine in patients with epilepsy.
Tsiropoulos I; Kristensen O; Klitgaard NA
Ther Drug Monit; 2000 Oct; 22(5):517-21. PubMed ID: 11034255
[TBL] [Abstract][Full Text] [Related]
11. A nonlinear mixed effects modelling analysis of topiramate pharmacokinetics in patients with epilepsy.
Vovk T; Jakovljević MB; Kos MK; Janković SM; Mrhar A; Grabnar I
Biol Pharm Bull; 2010; 33(7):1176-82. PubMed ID: 20606310
[TBL] [Abstract][Full Text] [Related]
12. Population Pharmacokinetics of Topiramate in Japanese Pediatric and Adult Patients With Epilepsy Using Routinely Monitored Data.
Takeuchi M; Yano I; Ito S; Sugimoto M; Yamamoto S; Yonezawa A; Ikeda A; Matsubara K
Ther Drug Monit; 2017 Apr; 39(2):124-131. PubMed ID: 28230619
[TBL] [Abstract][Full Text] [Related]
13. Age and antiepileptic drugs influence topiramate plasma levels in children.
Dahlin MG; Ohman IK
Pediatr Neurol; 2004 Oct; 31(4):248-53. PubMed ID: 15464635
[TBL] [Abstract][Full Text] [Related]
14. Topiramate pharmacokinetics in children with epilepsy aged from 6 months to 4 years.
Mikaeloff Y; Rey E; Soufflet C; d'Athis P; Echenne B; Vallée L; Bouhours P; Grinspan A; Dulac O; Pons G; Chiron C
Epilepsia; 2004 Nov; 45(11):1448-52. PubMed ID: 15509246
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with topiramate dosing and serum levels in patients with epilepsy.
Zanotta N; Raggi ME; Radice L; Degrate A; Bresolin N; Zucca C
Seizure; 2006 Mar; 15(2):86-92. PubMed ID: 16406695
[TBL] [Abstract][Full Text] [Related]
16. Lack of an effect of topiramate on lamotrigine serum concentrations.
Berry DJ; Besag FM; Pool F; Natarajan J; Doose D
Epilepsia; 2002 Aug; 43(8):818-23. PubMed ID: 12180999
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age.
Girgis IG; Nandy P; Nye JS; Ford L; Mohanty S; Wang S; Ochalski S; Eerdekens M; Cox E
Epilepsia; 2010 Oct; 51(10):1954-62. PubMed ID: 20880232
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with topiramate dosing and serum levels in children 12 years or under with epilepsy.
Schwabe MJ; Wheless JW
J Child Neurol; 2001 Nov; 16(11):806-8. PubMed ID: 11732765
[TBL] [Abstract][Full Text] [Related]
19. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
Rosenfeld WE; Doose DR; Walker SA; Nayak RK
Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
[TBL] [Abstract][Full Text] [Related]
20. Topiramate pharmacokinetics in infants.
Glauser TA; Miles MV; Tang P; Clark P; McGee K; Doose DR
Epilepsia; 1999 Jun; 40(6):788-91. PubMed ID: 10368080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
